ARMSTRONG, A.; AGADA, N.; XU, W.; GALLO, G. An Update on the Long-Term Safety Experience of Ixekizumab: Results from the Psoriasis Clinical Development Program with More than 3 Years of Follow-up from 12 Clinical Trials and More Than 15000 Patient-Years of Exposure to Ixekizumab. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, p. S116, 2018. DOI: 10.25251/skin.2.supp.105. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/498. Acesso em: 23 jul. 2024.